Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-16T18:57:07.324Z Has data issue: false hasContentIssue false
  • English
  • Français

Mediterranean diet and cystic fibrosis

Published online by Cambridge University Press:  08 March 2007

Birgitta Strandvik
Birgitta Strandvik*
Affiliation:
Department of PediatricsInstitute of the Health of Women and ChildrenSahlgrenska AcademyGöteborg UniversityGöteborgSweden
*
birgitta.strandvik@pediat.gu.se
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Invited Commentary
Information
British Journal of Nutrition , Volume 96 , Issue 2 , August 2006 , pp. 199 - 200
Copyright
Copyright © The Nutrition Society 2006

References

Beckles-Willson, N, Elliott, T & Everard, MLOmega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database of Systematic Reviews 2004 (2002) (3) CD002201CrossRefGoogle ScholarPubMed
Berguerand, M, Klapisz, E, Thomas, G, Humbert, L, Jouniaux, AM, Olivier, JL, Bereziat, G & Masliah, JDifferential stimulation of cytosolic phospholipase A2 by bradykinin in human cystic fibrosis cell lines. Am J Resp Cell Mol Biol (1997) 17 481–490CrossRefGoogle ScholarPubMed
Bhura-Bandali, FN, Suh, M, Man, SFP & Clandinin, MTThe dF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells. J Nutr (2000) 130 2870–2875CrossRefGoogle Scholar
Carlstedt-Duke, J, Brönnegård, M & Strandvik, BPathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect. Proc Natl Acad Sci U S A (1986) 83 9202–9206CrossRefGoogle ScholarPubMed
De Vizia, B, Raia, V, Spano, C, Pavlidis, C, Coruzzo, A & Alessio, MEffect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. J Parent Ent Nutr (2003) 27 52–57CrossRefGoogle ScholarPubMed
Farrell, PM, Mischler, EH, Engle, MJ, Brown, J & Lau, SMFatty acid abnormalities in cystic fibrosis. Pediatr Res (1985) 19 104–109CrossRefGoogle ScholarPubMed
Freedman, SD, Katz, MH, Parker, EM, Laposata, M, Urman, MY & Alvarez, JGA membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in CFTR –/– mice. Proc Natl Acad Sci U S A (1999) 96 13995–14000CrossRefGoogle Scholar
Karp, CL, Flick, LMYang, R, Uddin, J & Petasis, NACystic fibrosis and lipoxins. Prostaglandins Leukot Essent Fatty Acids (2005) 73 263–270CrossRefGoogle ScholarPubMed
Kuo, PT, Huang, NN & Bassett, DRThe fatty acid composition of the serum chylomicrons and adipose tissue of children with cystic fibrosis of the pancrease. J Pediatr (1962) 60 394–403CrossRefGoogle Scholar
Levistre, R, Lemnaouar, M, Rybkine, T, Bereziat, G & Masliah, JIncrease of bradykinin stimulated arachidonic acid release in a delta-F508 cystic fibrosis epithelial cell line. Biochim Biophys Acta (1993) 1181 233–239CrossRefGoogle Scholar
Lloyd-Still, JD, Bibus, DM, Powers, CA, Johnson, SB & Holman, RTEssential fatty acid deficiency and predisposition to lung disease in cystic fibrosis. Acta Paediatr (1996) 85 1426–1432CrossRefGoogle ScholarPubMed
Lloyd-Still, JD, Johnson, SB & Holman, RTEssential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation. Am J Clin Nutr (1981) 34 1–7CrossRefGoogle ScholarPubMed
Miele, L, Cordella-Miele, E, Xing, M, Frizell, R & Mukherjee, ABCystic fibrosis gene mutation (delta F508) is associated with an intrinsic abnormality in Ca2+ -induced arachidonic acid release by epithelial cells. DNA Cell Biol (1997) 16 749–759CrossRefGoogle Scholar
Mischler, EH, Parrell, SW, Farrell, PM, Raynor, WJ & Lemen, RJCorrection of linoleic acid deficiency in cystic fibrosis. Pediatr Res (1986) 20 36–41CrossRefGoogle ScholarPubMed
Olveira, G, Dorado, A, Olveira, C, Padilla, A, Rojo-Martinez, G, Garcia-Escobar, E, Gaspar, I, Gonzalo, M & Soriguer, FSerum phospholipid fatty acid profile and dietary intake in an adult Mediterranean population with cystic fibrosis. Br J Nutr (2006) 96 343–349CrossRefGoogle Scholar
Rogiers, V, Vercruysse, A, Dab, I & Baran, DAbnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency. Eur J Pediatr (1983) 141 39–42CrossRefGoogle ScholarPubMed
Serra-Majem, L, Ngo de la Cruz, J, Ribas, L & Salleras, LMediterranean diet and health: is all the secret in olive oil ?. Pathophysiol Haemost Thromb (2003/2004) 33 461–465CrossRefGoogle ScholarPubMed
Simopoulos, APEssential fatty acids in health and chronic disease. Am J Clin Nutr (1999) 70 560S–569SCrossRefGoogle ScholarPubMed
Strandvik, B, Gronowitz, E, Enlund, F, Martinsson, T & Wahlström, JEssential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. J Pediatr (2001) 139 650–655CrossRefGoogle ScholarPubMed
Strandvik, B, Svensson, E & Seyberth, HWProstanoid biosynthesis in patients with cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids (1996) 55 419–425CrossRefGoogle ScholarPubMed
Underwood, BA, Denning, CR & Navab, MPolyunsaturated fatty acids and tocopherol levels in patients with cystic fibrosis. Ann NY Acad Sci (1972) 203 237–247CrossRefGoogle ScholarPubMed
Van Biervliet, S, Van Biervliet, JP, Robberecht, E & Christophe, ADocosahexaenoic acid trials in cystic fibrosis: A review of the rationale behind the clinical trials. J Cyst Fibros (2005) 4 27–34CrossRefGoogle ScholarPubMed
Wood, LG, Fitzgerald, DA, Gibson, PG, Cooper, DM, Collins, CE & Garg, MLOxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr (2001) 20 157–165CrossRefGoogle ScholarPubMed